Skip to main content
. 2016 Oct 28;12(2):106–119. doi: 10.1002/cmdc.201600441

Table 2.

In vitro antitubercular activity of series 2 compounds.[a]

graphic file with name CMDC-12-106-g028.jpg
Compd R1 R2 MIC CC50 [b]
μg mL−1 μm μg mL−1 μm
16 a graphic file with name CMDC-12-106-g029.jpg H 7.7 17.0 14 30.9
16 b graphic file with name CMDC-12-106-g030.jpg H 6.4 13.7 12 25.7
16 c graphic file with name CMDC-12-106-g031.jpg H 3.8 8.9 8.9 20.8
16 d graphic file with name CMDC-12-106-g032.jpg Br 4.2 8.3 30 59.3
16 e graphic file with name CMDC-12-106-g033.jpg Br >32 >67.5 >64 >135.0
16 f graphic file with name CMDC-12-106-g034.jpg Br 2.0 4.0 9.2 18.4

[a] Reference compound: bedaquiline MIC=0.060 μg mL−1 (0.1 μm). [b] Concentration at which the growth of Vero cells is inhibited by 50 %.